A single-shot vaccine developed by the healthcare giant Johnson & Johnson is effective in preventing the most serious coronavirus symptoms, according to data from mass trials.

The company said its latest tests - carried out in several countries - also showed it was 66% effective overall at preventing moderate to severe COVID-19, 28 days after vaccination.

It comes as another coronavirus vaccine from Novavax could get the all-clear from UK regulators.

SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews

Follow us on Twitter: https://twitter.com/skynews

Like us on Facebook: https://www.facebook.com/skynews

Follow us on Instagram: https://www.instagram.com/skynews

For more content go to http://news.sky.com and download our apps:

Apple: https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8

Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB

Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog